We are live on ! Find out more
KXA

KPCB XIII Associates Portfolio holdings

AUM $186M
1-Year Est. Return 11.23%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
-11.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$486M
AUM Growth
-$132M
Cap. Flow
-$155M
Cap. Flow %
-31.95%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PGNY icon
Progyny
PGNY
+$131M
2
LUNG icon
Pulmonx
LUNG
+$24.5M
3
TMDX icon
Transmedics
TMDX
+$277K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGNY icon
1
Progyny
PGNY
$2.4B
$369M 75.9%
8,295,896
-2,797,800
-25% -$131M
LUNG icon
2
Pulmonx
LUNG
$51.5M
$45.5M 9.35%
994,971
-426,415
-30% -$24.5M
TMDX icon
3
Transmedics
TMDX
$2.46B
$38.3M 7.87%
923,221
-9,000
-1% -$277K
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$33.4M 6.87%
3,838,166
– –

Similar funds

BC
Bullfrog Capital Palo Alto, California $191M AUM 19.3% 1-Year Est. Return
CC
Claybrook Capital Wellesley, Massachusetts $175M AUM 10.74% 1-Year Est. Return
BAG
Briggs Advisory Group Lincoln, Rhode Island $175M AUM 16.29% 1-Year Est. Return
SWA
Sutton Wealth Advisors Tampa, Florida $203M AUM 20.54% 1-Year Est. Return
DLG
Daniel L. Goodwin $207M AUM 22.03% 1-Year Est. Return
NFAM
North Fourth Asset Management Englewood Cliffs, New Jersey $164M AUM 43.6% 1-Year Est. Return
RCGI
Ribbit Capital GP III Palo Alto, California $211M AUM 51.22% 1-Year Est. Return
TA
Trellis Advisors Ellensburg, Washington $219M AUM 17.82% 1-Year Est. Return

KPCB XIII Associates's Q1 2021 Portfolio in Review

As of Q1 2021, KPCB XIII Associates held 4 positions worth $486M, down 21% from $619M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XIII Associates withdrew a net $155M in Q1 2021, reducing 3 holdings. Its largest reduction was Progyny, cutting an estimated $131M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • KPCB XIII Associates's biggest Q1 2021 reduction was Progyny, cutting an estimated $131M.
  • KPCB XIII Associates's ten largest holdings make up 100% of its $486M portfolio in Q1 2021.
  • KPCB XIII Associates opened 0 new positions and closed 0 in Q1 2021.
  • KPCB XIII Associates's portfolio value fell 21% quarter-over-quarter to $486M.

Based on KPCB XIII Associates's 13F filing for Q1 2021, filed 13 May 2021.